Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions

Molecular Endocrinology

Volumn 22, Issue 5, 2008, Pages 1238-1250

  Mukherjee, Aditi ^a   Rotwein, Peter ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 5;

ANIMAL EXPERIMENT; ARTICLE; BONE GROWTH; BONE MINERALIZATION; BONE REMODELING; CELL DIFFERENTIATION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETON;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; METATARSAL BONES; MICE; MICE, INBRED C3H; OSTEOBLASTS; PREGNANCY; SOMATOMEDINS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRIDAE;

EID: 43049104172     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0001     Document Type: Article

References (80)

1. Marks Jr SC, Popoff SN 1988 Bone cell biology: the regulation of development, structure, and function in the skeleton. Am J Anat 183:1-44
2. Hadjidakis DJ, Androulakis II 2006 Bone remodeling. Ann NY Acad Sci 1092:385-396
3. Huang W, Yang S, Shao J, Li YP 2007 Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci 12:3068-3092
4. Rosen CJ, Donahue LR 1998 Insulin-like growth factors and bone: the osteoporosis connection revisited. Proc Soc Exp Biol Med 219:1-7
5. Nakae J, Kido Y, Accili D 2001 Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev 22:818-835
6. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72
7. Zhang M, Xuan S, Bouxsein ML, von SD, Akeno N, Faugere MC, Malluche H, Zhao G, Rosen CJ, Efstratiadis A, Clemens TL 2002 Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 277:44005-44012
8. Zhao G, Monier-Faugere MC, Langub MC, Geng Z, Nakayama T, Pike JW, Chernausek SD, Rosen CJ, Donahue LR, Malluche HH, Fagin JA, Clemens TL 2000 Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141:2674-2682
9. Duan C, Xu Q 2005 Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. Gen Comp Endocrinol 142:44-52
10. Bach LA, Headey SJ, Norton RS 2005 IGF-binding proteins: the pieces are falling into place. Trends Endocrinol Metab 16:228-234
11. Mohan S, Baylink DJ 2002 IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol 175:19-31
12. Govoni KE, Baylink DJ, Mohan S 2005 The multi-functional role of insulin-like growth factor binding proteins in bone. Pediatr Nephrol 20:261-268
13. Mohan S 1993 Insulin-like growth factor binding proteins in bone cell regulation. Growth Regul 3:67-70
14. Grellier P, Yee D, Gonzalez M, Abboud SL 1995 Characterization of insulin-like growth factor binding proteins (IGFBP) and regulation of IGFBP-4 in bone marrow stromal cells. Br J Haematol 90:249-257
15. Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C, Lang K, Baylink DJ 1995 Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 270:20424-20431
16. Zhang M, Faugere MC, Malluche H, Rosen CJ, Chernausek SD, Clemens TL 2003 Paracrine overexpression of IGFBP-4 in osteoblasts of transgenic mice decreases bone turnover and causes global growth retardation. J Bone Miner Res 18:836-843
17. Conover C 2008 Insulin-like growth factor binding proteins and bone metabolism. Am J Physiol Endocrinol Metab 294:E10-E14
18. Mukherjee A, Rotwein P 2007 Insulin-like growth factor binding protein-5 in osteogenesis: facilitator or inhibitor? Growth Horm IGF Res 17:179-185
19. Schneider MR, Wolf E, Hoeflich A, Lahm H 2002 IGF-binding protein-5: flexible player in the IGF system and effector on its own. J Endocrinol 172:423-440
20. Beattie J, Allan GJ, Lochrie JD, Flint DJ 2006 Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis. Biochem J 395:1-19
21. Kalus W, Zweckstetter M, Renner C, Sanchez Y, Georgescu J, Grol M, Demuth D, Schumacher R, Dony C, Lang K, Holak TA 1998 Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions. EMBO J 17:6558-6572
22. Zeslawski W, Beisel HG, Kamionka M, Kalus W, Engh RA, Huber R, Lang K, Holak TA 2001 The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5. EMBO J 20:3638-3644
23. Imai Y, Moralez A, Andag U, Clarke JB, Busby Jr WH, Clemmons DR 2000 Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions. J Biol Chem 275:18188-18194
24. Song H, Beattie J, Campbell IW, Allan GJ 2000 Overlap of IGF- and heparin-binding sites in rat IGF-binding protein-5. J Mol Endocrinol 24:43-51
25. Parker A, Rees C, Clarke J, Busby Jr WH, Clemmons DR 1998 Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I. Mol Biol Cell 9:2383-2392
26. Arai T, Parker A, Busby Jr W, Clemmons DR 1994 Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes. J Biol Chem 269:20388-20393
27. Olney RC, Mougey EB 1999 Expression of the components of the insulin-like growth factor axis across the growth-plate. Mol Cell Endocrinol 156:63-71
28. Kiepe D, Ciarmatori S, Haarmann A, Tonshoff B 2006 Differential expression of IGF system components in proliferating vs. differentiating growth plate chondrocytes: the functional role of IGFBP-5. Am J Physiol Endocrinol Metab 290:E363-E371
29. Bautista CM, Baylink DJ, Mohan S 1991 Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. Biochem Biophys Res Commun 176:756-763
30. Ning Y, Schuller AG, Bradshaw S, Rotwein P, Ludwig T, Frystyk J, Pintar JE 2006 Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5. Mol Endocrinol 20:2173-2186
31. Devlin RD, Du Z, Buccilli V, Jorgetti V, Canalis E 2002 Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia. Endocrinology 143:3955-3962
32. Salih DA, Mohan S, Kasukawa Y, Tripathi G, Lovett FA, Anderson NF, Carter EJ, Wergedal JE, Baylink DJ, Pell JM 2005 Insulin-like growth factor-binding protein-5 induces a gender-related decrease in bone mineral density in transgenic mice. Endocrinology 146:931-940
33. Bauss F, Lang K, Dony C, Kling L 2001 The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration. Growth Horm IGF Res 11:1-9
34. Miyakoshi N, Richman C, Kasukawa Y, Linkhart TA, Baylink DJ, Mohan S 2001 Evidence that IGF-binding protein-5 functions as a growth factor. J Clin Invest 107:73-81
35. Richman C, Baylink DJ, Lang K, Dony C, Mohan S 1999 Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. Endocrinology 140:4699-4705
36. Schneider MR, Zhou R, Hoeflich A, Krebs O, Schmidt J, Mohan S, Wolf E, Lahm H 2001 Insulin-like growth factor-binding protein-5 inhibits growth and induces differentiation of mouse osteosarcoma cells. Biochem Biophys Res Commun 288:435-442
37. Durant D, Pereira RM, Canalis E 2004 Overexpression of insulin-like growth factor binding protein-5 decreases osteoblastic function in vitro. Bone 35:1256-1262
38. Conover CA, Kiefer MC 1993 Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells. J Clin Endocrinol Metab 76:1153-1159
39. Wozney JM 1992 The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 32:160-167
40. Li X, Cao X 2006 BMP signaling and skeletogenesis. Ann NY Acad Sci 1068:26-40
41. Lee MH, Kim YJ, Yoon WJ, Kim JI, Kim BG, Hwang YS, Wozney JM, Chi XZ, Bae SC, Choi KY, Cho JY, Choi JY, Ryoo HM 2005 Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J Biol Chem 280:35579-35587
42. Lee MH, Kim YJ, Kim HJ, Park HD, Kang AR, Kyung HM, Sung JH, Wozney JM, Kim HJ, Ryoo HM 2003 BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-β1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 278:34387-34394
43. Ito Y, Miyazono K 2003 RUNX transcription factors as key targets of TGF-β superfamily signaling. Curr Opin Genet Dev 13:43-47
44. Mukherjee A, Wilson EM, Rotwein P 2008 IGF binding protein-5 blocks skeletal muscle differentiation by inhibiting IGF actions. Mol Endocrinol 22:206-215
45. Andress DL, Birnbaum RS 1992 Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 267:22467-22472
46. Yin P, Xu Q, Duan C 2004 Paradoxical actions of endogenous and exogenous insulin-like growth factor-binding protein-5 revealed by RNA interference analysis. J Biol Chem 279:32660-32666
47. Butt AJ, Dickson KA, McDougall F, Baxter RC 2003 Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J Biol Chem 278:29676-29685
48. Francis GL, Aplin SE, Milner SJ, McNeil KA, Ballard FJ, Wallace JC 1993 Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II. Biochem J 293(Pt 3):713-719
49. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G 1997 Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747-754
50. Buckwalter JA, Glimcher MJ, Cooper RR, Recker R 1996 Bone biology. II. Formation, form, modeling, remodeling, and regulation of cell function. Instr Course Lect 45:387-399
51. Krishnan V, Moore TL, Ma YL, Helvering LM, Frolik CA, Valasek KM, Ducy P, Geiser AG 2003 Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling. Mol Endocrinol 17:423-435
52. Mukherjee A, Dong SS, Clemens T, Alvarez J, Serra R 2005 Co-ordination of TGF-β and FGF signaling pathways in bone organ cultures. Mech Dev 122:557-571
53. Serra R, Karaplis A, Sohn P 1999 Parathyroid hormone-related peptide (PTHrP)-dependent and -independent effects of transforming growth factor β (TGF-β) on endochondral bone formation. J Cell Biol 145:783-794
54. Krishnan V, Ma Y, Moseley J, Geiser A, Friant S, Frolik C 2001 Bone anabolic effects of Sonic/Indian hedgehog are mediated by BMP-2/4-dependent pathways in the neonatal rat metatarsal model. Endocrinology 142:940-947
55. Schedlich LJ, Muthukaruppan A, O'Han MK, Baxter RC 2007 Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts. Mol Endocrinol 21:2378-2390
56. Amaar YG, Thompson GR, Linkhart TA, Chen ST, Baylink DJ, Mohan S 2002 Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2). J Biol Chem 277:12053-12060
57. Noda M, Nifuji A, Tuji K, Furuya K, Ichiro S, Asou Y, Kawaguchi N, Yamachita K 1998 Transcription factors and osteoblasts. Front Biosci 3:d817-d820
58. Hoshi K, Ejiri S, Ozawa H 2000 Ultrastructural, cytochemical, and biophysical aspects of mechanisms of bone matrix calcification. Kaibogaku Zasshi 75:457-465
59. Balcerzak M, Hamade E, Zhang L, Pikula S, Azzar G, Radisson J, Bandorowicz-Pikula J, Buchet R 2003 The roles of annexins and alkaline phosphatase in mineralization process. Acta Biochim Pol 50:1019-1038
60. Palmer G, Bonjour JP, Caverzasio J 1997 Expression of a newly identified phosphate transporter/retrovirus receptor in human SaOS-2 osteoblast-like cells and its regulation by insulin-like growth factor I. Endocrinology 138:5202-5209
61. Selz T, Caverzasio J, Bonjour JP 1989 Regulation of Na-dependent Pi transport by parathyroid hormone in osteoblast-like cells. Am J Physiol 256:E93-E100
62. Carter DR, Beaupre GS, Giori NJ, Helms JA 1998 Mechanobiology of skeletal regeneration. Clin Orthop Relat Res 355(Suppl):S41-S55
63. Ferguson CM, Miclau T, Hu D, Alpern E, Helms JA 1998 Common molecular pathways in skeletal morphogenesis and repair. Ann NY Acad Sci 857:33-42
64. Wilson EM, Hsieh MM, Rotwein P 2003 Autocrine growth factor signaling by insulin-like growth factor-II mediates MyoD-stimulated myocyte maturation. J Biol Chem 278:41109-41113
65. Tureckova J, Wilson EM, Cappalonga JL, Rotwein P 2001 Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J Biol Chem 276:39264-39270
66. Wilson EM, Rotwein P 2007 Selective control of skeletal muscle differentiation by Akt1. J Biol Chem 282:5106-5110
67. Ghosh-Choudhury N, Mandal CC, Choudhury GG 2007 Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation. J Biol Chem 282:4983-4993
68. Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, Choudhury GG 2002 Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem 277:33361-33368
69. Osyczka AM, Leboy PS 2005 Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. Endocrinology 146:3428-3437
70. Fujita T, Azuma Y, Fukuyama R, Hattori Y, Yoshida C, Koida M, Ogita K, Komori T 2004 Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J Cell Biol 166:85-95
71. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman KG, Hay N 2003 Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17:1352-1365
72. Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X, Wu H 1999 PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA 96:6199-6204
73. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW 1998 Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29-39
74. Liu X, Bruxvoort KJ, Zylstra CR, Liu J, Cichowski R, Faugere MC, Bouxsein ML, Wan C, Williams BO, Clemens TL 2007 Lifelong accumulation of bone in mice lacking Pten in osteoblasts. Proc Natl Acad Sci USA 104:2259-2264
75. Celil AB, Campbell PG 2005 BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol Chem 280:31353-31359
76. Celil AB, Hollinger JO, Campbell PG 2005 Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling. J Cell Biochem 95:518-528
77. Ducy P, Karsenty G 1995 Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15:1858-1869
78. Wilson EM, Tureckova J, Rotwein P 2004 Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation. Mol Biol Cell 15:497-505
79. Manolagas SC, Burton DW, Deftos LJ 1981 1,25-Dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells. J Biol Chem 256:7115-7117
80. Abdallah BM, Haack-Sorensen M, Fink T, Kassem M 2006 Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females. Bone 39:181-188